Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

30 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
[Recommendations for the diagnosis and treatment of classic forms of 21-hydroxylase-deficient congenital adrenal hyperplasia].
Rodríguez A, Ezquieta B, Labarta JI, Clemente M, Espino R, Rodriguez A, Escribano A; en representación del grupo de Hiperplasia Suprarrenal Congénita de la Sociedad Española de Endocrinología Pediátrica. Rodríguez A, et al. Among authors: espino r. An Pediatr (Barc). 2017 Aug;87(2):116.e1-116.e10. doi: 10.1016/j.anpedi.2016.12.002. Epub 2017 Feb 1. An Pediatr (Barc). 2017. PMID: 28161392 Free article. Spanish.
A follow-up study to monitor adult height among Spanish children with growth hormone deficiency who received biosimilar human recombinant growth hormone (Omnitrope®) during a phase III clinical trial.
Borrás Pérez V, López-Siguero JP, Martínez G, Corripio R, Fernández JM, Labarta JI, Ferrer M, Cabrinety N, Prieto P, Ramón-Krauel M, Bosch J, Espino R, Palla Garcia M, Rebollo FJ. Borrás Pérez V, et al. Among authors: espino r. Adv Ther. 2015 Feb;32(2):148-56. doi: 10.1007/s12325-015-0181-9. Epub 2015 Feb 11. Adv Ther. 2015. PMID: 25667132 Free PMC article.
Effect of recombinant growth hormone on leptin, adiponectin, resistin, interleukin-6, tumor necrosis factor-α and ghrelin levels in growth hormone-deficient children.
López-Siguero JP, López-Canti LF, Espino R, Caro E, Fernández-García JM, Gutiérrez-Macías A, Rial JM, Lechuga JL, Macías F, Martínez-Aedo MJ, Rico S, Rodríguez I, Guillén J, Arroyo FJ, Bernal S, Espigares R, Núñez M, Escribano A, Barrionuevo JL, Gentil J, Barrios V, Fernández-Nistal A, Martos-Moreno GA, Martínez V, Argente J. López-Siguero JP, et al. Among authors: espino r. J Endocrinol Invest. 2011 Apr;34(4):300-6. doi: 10.1007/BF03347090. Epub 2010 Jul 13. J Endocrinol Invest. 2011. PMID: 20634639 Clinical Trial.
A novel dysfunctional growth hormone variant (Ile179Met) exhibits a decreased ability to activate the extracellular signal-regulated kinase pathway.
Lewis MD, Horan M, Millar DS, Newsway V, Easter TE, Fryklund L, Gregory JW, Norin M, Del Valle CJ, López-Siguero JP, Cañete R, López-Canti LF, Díaz-Torrado N, Espino R, Ulied A, Scanlon MF, Procter AM, Cooper DN. Lewis MD, et al. Among authors: espino r. J Clin Endocrinol Metab. 2004 Mar;89(3):1068-75. doi: 10.1210/jc.2003-030652. J Clin Endocrinol Metab. 2004. PMID: 15001589
30 results